LINDSEY LAMM: Open Payments
NPI 1346778073 · COLDWATER, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$481 in 28 payments from 12 companies in 2025. Trend: 2023 $30 · 2024 $232 · 2025 $481
Food & beverage: $481
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $127 |
| AstraZeneca Pharmaceuticals LP | 5 | $76 |
| Amgen Inc. | 3 | $49 |
| Esperion Therapeutics, Inc. | 2 | $37 |
| PFIZER INC. | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Lilly USA, LLC | 2 | $31 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Actelion Pharmaceuticals US, Inc. | 1 | $19 |
Products named: Ozempic, FARXIGA, NEXLETOL, XIFAXAN, MOUNJARO, Wegovy, AIRSUPRA, TRELEGY ELLIPTA.
Industry payments across OH — which companies pay providers there.
